This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

trusted source

proofread

Study shows donor kidneys with toxoplasma do not increase risks for transplant patients

kidneys
Credit: Unsplash/CC0 Public Domain

A new study from UC Davis Health could help to increase the supply of donor kidneys.

Researchers have found that transplant patients who receive kidneys infected with the parasite have virtually the same outcomes as those who receive toxoplasma-negative organs.

Despite longstanding concerns, those who received kidneys from toxoplasma antibody positive donors (TPDs) had almost identical mortality and rejection rates. The research is published in Transplant International.

"Organs from donors who were positive for toxoplasma did just as well as organs from those who were negative, both for survival of the patients and survival of the kidneys," said Lavjay Butani, chief of pediatric nephrology. He coauthored the paper with Daniel Tancredi, professor of pediatrics. "This is quite encouraging."

Inconsistency in approach

Toxoplasma is a ubiquitous parasite that infects many people but generally causes no harm. However, people who are immunosuppressed, such as kidney recipients, could be at higher risk. Toxoplasmosis can be transmitted through the transplanted kidney and reactivate a latent infection in the kidney recipient.

Still, there has been tremendous inconsistency in how transplant centers treat TPD kidneys, with some accepting them and others rejecting.

"We conducted this study because about a year ago, there was a positive donor and the team did not want to use that for one of our , so we didn't accept it," Butani said. "But we realized, we just didn't have the data to know if that was the correct decision."

What the study showed

The study analyzed 51,000 transplants from the Organ Procurement and Transplantation Network database. Of those, 4,300 were TPD. They found that rejection and graft failure was 5% for both TPD and non-TPD kidneys. Other measures were similarly aligned. In other words, the TPD kidneys posed no additional risk.

The authors believe it is safe to transplant TPD kidneys—but do recommend additional monitoring. However, transplant patients routinely receive Bactrim, a two-antibiotic combination that is effective against toxoplasma and this may already be mitigating their risk. Most patients receive Bactrim for a year, but that could be extended for TPD cases.

The authors hope this work will help unify their TPD policies. UC Davis Health is currently writing new protocols for pediatric transplants. Ultimately, this new understanding could help patients get the organs they desperately need.

"In transplants, kidneys are the greatest need," Butani said. "Because of increased diabetes, and other conditions, the wait list just gets progressively longer. We hope these findings will help increase the supply of kidneys."

More information: Lavjay Butani et al, Outcomes of Kidney Transplants From Toxoplasma-Positive Donors: An Organ Procurement and Transplant Network Database Analysis, Transplant International (2024). DOI: 10.3389/ti.2024.13203

Provided by UC Davis
Citation: Study shows donor kidneys with toxoplasma do not increase risks for transplant patients (2024, August 7) retrieved 7 August 2024 from https://medicalxpress.com/news/2024-08-donor-kidneys-toxoplasma-transplant-patients.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Pediatric kidney transplant patients fare better when kidney is from live donor

0 shares

Feedback to editors